The ECNP New Frontiers Meeting fosters high-level exchange between scientists, industry leaders, and regulators to bridge the gap between research and treatment development. It provides a neutral platform for cross-sector collaboration in CNS research, aiming to advance new therapies. The topic and committee are selected annually through an open call in September.
The membership of the programme committee is designed to represent a cross-section of the leading academic researchers, industry scientists, regulators and patient representatives in the neural circuits in psychiatry field.
